Position in ANNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$965,345
-$2,799,655 QoQ
Shares Held
174,250
-76.8% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.97%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ishara Investments LP holds $93,075,669 across 35 Biotechnology names. ANNX ranks #31 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
22,550 | $7,265,384 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
41,000 | $6,929,820 | |
| 3 | KALV |
KalVista Pharmaceuticals, Inc.
|
276,750 | $5,570,977 | |
| 4 | FOLD |
AMICUS THERAPEUTICS, INC.
|
369,000 | $5,335,740 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
82,000 | $4,632,180 | |
| 6 | VSTM |
Verastem, Inc.
|
820,000 | $4,346,000 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
174,250 | $3,650,537 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
55,350 | $3,470,445 |
All Filings in ANNX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $965,345 | 174,250 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,765,000 | 750,000 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||